An open clinical evaluation on THANDAGAVADHAM (Lumbar Spondylosis) treated with VARMAM and AANAI THIPILI DHRAVAGAM (Internal) and KAYATHIRUMENI ENNAI (External)

This is a phase II, non-randomized, comparative an open clinical evaluation of Varmam and Siddha trial drugs "Aanai thipili dhravagam" (internal) and "Kayathirumeni ennai" (external) for Thandagavadham (lumbarspondylosis). The

dosage of internal medication Aanai thipili dhravagam is 2 ml along with 30ml of water and will be administered twice a day after a meal. The time period of medication will be around 21 days and a sufficient amount of Kayathirumeni ennai will be given for 21days . The sample size for this study is 90 which will be categorized into 3 groups.  The first group will be given Varmam therapy, the second group will be given both internal and external medication and the final group will be given internal, external and varmam therapy. The trial drug Aanai thipili dhravagam contains some active herbs that possess anti-inflammatory, analgesic which will be helpful to reduce the symptoms of Lumbar spondylosis.